-
Signature
-
/s/ Christine Pellizzari, Attorney-in-fact for Emily Rollins
-
Stock symbol
-
SNCE
-
Transactions as of
-
Mar 12, 2024
-
Transactions value $
-
-$11,788
-
Form type
-
4
-
Date filed
-
3/12/2024, 10:06 AM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
SNCE |
Common Stock |
Disposition pursuant to a tender of shares in a change of control transaction |
-$11.8K |
-2.05K |
-100% |
$5.75 |
0 |
Mar 12, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
SNCE |
Restricted Stock Units |
Disposed to Issuer |
|
-24.7K |
-100% |
|
0 |
Mar 12, 2024 |
Common Stock |
24.7K |
|
Direct |
F2, F3 |
transaction |
SNCE |
Stock Option |
Disposed to Issuer |
|
-1.38K |
-100% |
|
0 |
Mar 12, 2024 |
Common Stock |
1.38K |
$201.00 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Emily Rollins is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses:
Remarks:
On December 8, 2023, the Issuer effected a reverse stock split of Issuer Common Stock at a ratio of 1-for-20 (the "Reverse Stock Split"). As a result of the Reverse Stock Split, the shares of Issuer Common Stock, and the exercise price and shares of Issuer Common Stock underlying outstanding equity awards, have been adjusted accordingly versus any amounts previously reported by the Reporting Person.